Association between BDNF levels and suicidal behaviour: A systematic review and meta-analysis

Systematic Reviews

Volumn 4, Issue 1, 2015, Pages

  Eisen, Rebecca B ^a   Perera, Stefan ^a   Banfield, Laura ^a   Anglin, Rebecca ^a   Minuzzi, Luciano ^a,b   Samaan, Zainab ^a,b,c  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

Author keywords

Attempted suicide; Brain derived neurotrophic factor; Meta analysis; Suicidal ideation; Suicide; Systematic review

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; BIOLOGICAL MARKER; BRAIN-DERIVED NEUROTROPHIC FACTOR, HUMAN;

ARTICLE; BIBLIOGRAPHIC DATABASE; CLINICAL EVALUATION; EVIDENCE BASED PRACTICE; HUMAN; INFORMATION PROCESSING; METHODOLOGY; NERVOUS SYSTEM FUNCTION; OBSERVATIONAL STUDY; PRIORITY JOURNAL; QUALITATIVE RESEARCH; RISK ASSESSMENT; RISK FACTOR; SCIENTIFIC LITERATURE; SUICIDAL BEHAVIOR; SUICIDAL IDEATION; SYSTEMATIC REVIEW; BLOOD; MENTAL DISEASE; META ANALYSIS; PSYCHOLOGY; SUICIDE ATTEMPT;

BIOMARKERS; BRAIN-DERIVED NEUROTROPHIC FACTOR; HUMANS; MENTAL DISORDERS; OBSERVATIONAL STUDIES AS TOPIC; RISK FACTORS; SUICIDAL IDEATION; SUICIDE, ATTEMPTED;

EID: 84952769807     PISSN: None     EISSN: 20464053     Source Type: Journal    
DOI: 10.1186/s13643-015-0179-z     Document Type: Article

References (48)

1. WHO. Preventing suicide: a global imperative. 2014.
2. Mann JJ. Neurobiology of suicidal behaviour. Nat Rev Neurosci. 2003;4(10):819-28. doi: 10.1038/nrn1220.
3. Crump C, Sundquist K, Sundquist J, Winkleby MA. Sociodemographic, psychiatric and somatic risk factors for suicide: a Swedish national cohort study. Psychol Med. 2014;44(2):279-89. doi: 10.1017/S0033291713000810.
4. Harris EC, Barraclough B. Suicide as an outcome for mental disorders. A meta-analysis. Br J Psychiatry. 1997;170:205-28.
5. Clayden RC, Zaruk A, Meyre D, Thabane L, Samaan Z. The association of attempted suicide with genetic variants in the SLC6A4 and TPH genes depends on the definition of suicidal behavior: a systematic review and meta-analysis. Transl Psychiatry. 2012;2, e166. doi: 10.1038/tp.2012.96.
6. Dwivedi Y. Brain-derived neurotrophic factor in suicide pathophysiology. In: Dwivedi Y, editor. The Neurobiological Basis of Suicide. Frontiers in Neuroscience. Boca Raton (FL). 2012.
7. Huang EJ, Reichardt LF. Neurotrophins: roles in neuronal development and function. Annu Rev Neurosci. 2001;24:677-736. doi: 10.1146/annurev.neuro.24.1.677.
8. Altshuler LL, Casanova MF, Goldberg TE, Kleinman JE. The hippocampus and parahippocampus in schizophrenic, suicide, and control brains. Arch Gen Psychiatry. 1990;47(11):1029-34.
9. Rajkowska G. Morphometric methods for studying the prefrontal cortex in suicide victims and psychiatric patients. Ann N Y Acad Sci. 1997;836(1):253-68.
10. Wagner G, Schultz CC, Koch K, Schachtzabel C, Sauer H, Schlosser RG. Prefrontal cortical thickness in depressed patients with high-risk for suicidal behavior. J Psychiatr Res. 2012;46(11):1449-55. doi: 10.1016/j.jpsychires.2012.07.013.
11. Eastwood SL, Harrison PJ. Synaptic pathology in the anterior cingulate cortex in schizophrenia and mood disorders. A review and a Western blot study of synaptophysin, GAP-43 and the complexins. Brain Res Bull. 2001;55(5):569-78.
12. Sackeim HA. Functional brain circuits in major depression and remission. Arch Gen Psychiatry. 2001;58(7):649-50.
13. Garcia R. Stress, synaptic plasticity, and psychopathology. Rev Neurosci. 2002;13(3):195-208.
14. Fossati P, Radtchenko A, Boyer P. Neuroplasticity: from MRI to depressive symptoms. Eur Neuropsychopharmacol. 2004;14 Suppl 5:S503-10. doi: 10.1016/j.euroneuro.2004.09.001.
15. Araya AV, Orellana X, Espinoza J. Evaluation of the effect of caloric restriction on serum BDNF in overweight and obese subjects: preliminary evidences. Endocrine. 2008;33(3):300-4.
16. Seifert T, Brassard P, Wissenberg M, Rasmussen P, Nordby P, Stallknecht B, et al. Endurance training enhances BDNF release from the human brain. Am J Physiol Regul Integr Comp Physiol. 2010;298(2):R372-7. doi: 10.1152/ajpregu.00525.2009.
17. Molendijk ML, Spinhoven P, Polak M, Bus BA, Penninx BW, Elzinga BM. Serum BDNF concentrations as peripheral manifestations of depression: evidence from a systematic review and meta-analyses on 179 associations (N = 9484). Mol Psychiatry. 2014;19(7):791-800. doi: 10.1038/mp.2013.105.
18. Bus BA, Molendijk ML, Penninx BJ, Buitelaar JK, Kenis G, Prickaerts J, et al. Determinants of serum brain-derived neurotrophic factor. Psychoneuroendocrinology. 2011;36(2):228-39. doi: 10.1016/j.psyneuen.2010.07.013.
19. Karege F, Perret G, Bondolfi G, Schwald M, Bertschy G, Aubry JM. Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Res. 2002;109(2):143-8.
20. Terracciano A, Lobina M, Piras MG, Mulas A, Cannas A, Meirelles O, et al. Neuroticism, depressive symptoms, and serum BDNF. Psychosom Med. 2011;73(8):638-42. doi: 10.1097/PSY.0b013e3182306a4f.
21. Karege F, Bondolfi G, Gervasoni N, Schwald M, Aubry JM, Bertschy G. Low brain-derived neurotrophic factor (BDNF) levels in serum of depressed patients probably results from lowered platelet BDNF release unrelated to platelet reactivity. Biol Psychiatry. 2005;57(9):1068-72. doi: 10.1016/j.biopsych.2005.01.008.
22. Paska AV, Zupanc T, Pregelj P. The role of brain-derived neurotrophic factor in the pathophysiology of suicidal behavior. Psychiatr Danub. 2013;25 Suppl 2:S341-4.
23. Smith MA, Makino S, Kvetnansky R, Post RM. Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus. J Neurosci. 1995;15(3 Pt 1):1768-77.
24. Fuchikami M, Morinobu S, Kurata A, Yamamoto S, Yamawaki S. Single immobilization stress differentially alters the expression profile of transcripts of the brain-derived neurotrophic factor (BDNF) gene and histone acetylation at its promoters in the rat hippocampus. Int J Neuropsychopharmacol. 2009;12(1):73-82. doi: 10.1017/S1461145708008997.
25. Rasmusson AM, Shi L, Duman R. Downregulation of BDNF mRNA in the hippocampal dentate gyrus after re-exposure to cues previously associated with footshock. Neuropsychopharmacology. 2002;27(2):133-42. doi: 10.1016/S0893-133X(02)00286-5.
26. Pizarro JM, Lumley LA, Medina W, Robison CL, Chang WE, Alagappan A, et al. Acute social defeat reduces neurotrophin expression in brain cortical and subcortical areas in mice. Brain Res. 2004;1025(1-2):10-20. doi: 10.1016/j.brainres.2004.06.085.
27. Dwivedi Y, Rizavi HS, Conley RR, Roberts RC, Tamminga CA, Pandey GN. Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects. Arch Gen Psychiatry. 2003;60(8):804-15. doi: 10.1001/archpsyc.60.8.804.
28. Karege F, Vaudan G, Schwald M, Perroud N, La Harpe R. Neurotrophin levels in postmortem brains of suicide victims and the effects of antemortem diagnosis and psychotropic drugs. Brain Res Mol Brain Res. 2005;136(1-2):29-37. doi: 10.1016/j.molbrainres.2004.12.020.
29. Deveci A, Aydemir O, Taskin O, Taneli F, Esen-Danaci A. Serum BDNF levels in suicide attempters related to psychosocial stressors: a comparative study with depression. Neuropsychobiology. 2007;56(2-3):93-7. doi: 10.1159/000111539.
30. Kim YK, Lee HP, Won SD, Park EY, Lee HY, Lee BH, et al. Low plasma BDNF is associated with suicidal behavior in major depression. Prog Neuro-Psychopharmacol Biol Psychiatry. 2007;31(1):78-85. doi: 10.1016/j.pnpbp.2006.06.024.
31. Lee BH, Kim H, Park SH, Kim YK. Decreased plasma BDNF level in depressive patients. J Affect Disord. 2007;101(1-3):239-44. doi: 10.1016/j.jad.2006.11.005.
32. Eisen R, Perera S, Bawor M, Banfield L, Anglin R, Minuzzi L, et al. Association between BDNF levels and suicidal behaviour: a systematic review protocol. Systematic Reviews. 2015;4(1):56. doi: 10.1186/s13643-015-0047-x.
33. Viera AJ, Garrett JM. Understanding interobserver agreement: the kappa statistic. Fam Med. 2005;37(5):360-3.
34. Liang W, Zhang H-M, Zhang H-Y, L-X LV. Association of brain-derived neurotrophic factor in peripheral blood and gene expression to suicidal behaviour in patients with depression. Chin Ment Health J. 2012;26(10):5.
35. Wells GA, Shea B, O'connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2000.
36. Higgins JPT, Green S, Cochrane Collaboration. Cochrane handbook for systematic reviews of interventions. Cochrane book series. Chichester, England. Hoboken, NJ: Wiley-Blackwell 2008.
37. Grah M, Mihanovic M, Ruljancic N, Restek-Petrovic B, Molnar S, Jelavic S. Brain-derived neurotrophic factor as a suicide factor in mental disorders. Acta neuropsychiatrica. 2014:1-8. doi: 10.1017/neu.2014.27
38. Pinheiro RT, Pinheiro KA, da Cunha Coelho FM, de Avila Quevedo L, Gazal M, da Silva RA, et al. Brain-derived neurotrophic factor levels in women with postpartum affective disorder and suicidality. Neurochem Res. 2012;37(10):2229-34. doi: 10.1007/s11064-012-0851-9.
39. Banerjee R, Ghosh AK, Ghosh B, Bhattacharyya S, Mondal AC. Decreased mRNA and protein expression of BDNF, NGF, and their receptors in the hippocampus from suicide: an analysis in human postmortem brain. Clin Med Insights Pathol. 2013;6:1-11. doi: 10.4137/CMPath.S12530.
40. Maheu ME, Davoli MA, Turecki G, Mechawar N. Amygdalar expression of proteins associated with neuroplasticity in major depression and suicide. J Psychiatr Res. 2013;47(3):384-90. doi: 10.1016/j.jpsychires.2012.11.013.
41. Martinez JM, Garakani A, Yehuda R, Gorman JM. Proinflammatory and "resiliency" proteins in the CSF of patients with major depression. Depress Anxiety. 2012;29(1):32-8. doi: 10.1002/da.20876.
42. Park YM, Lee BH, Um TH, Kim S. Serum BDNF levels in relation to illness severity, suicide attempts, and central serotonin activity in patients with major depressive disorder: a pilot study. PLoS One. 2014;9(3), e91061. doi: 10.1371/journal.pone.0091061.
43. Huang TL, Lee CT. Associations between serum brain-derived neurotrophic factor levels and clinical phenotypes in schizophrenia patients. J Psychiatr Res. 2006;40(7):664-8. doi: 10.1016/j.jpsychires.2005.11.004.
44. Cohen J. Statistical power analysis for the behavioral sciences. 1977. rev. Lawrence Erlbaum Associates, Inc.
45. Lee BH, Kim YK. Reduced platelet BDNF level in patients with major depression. Prog Neuro-Psychopharmacol Biol Psychiatry. 2009;33(5):849-53. doi: 10.1016/j.pnpbp.2009.04.002.
46. Lewis DA. The human brain revisited: opportunities and challenges in postmortem studies of psychiatric disorders. Neuropsychopharmacology. 2002;26(2):143-54. doi: 10.1016/S0893-133X(01)00393-1.
47. Dwivedi Y, Rizavi HS, Pandey GN. Antidepressants reverse corticosterone-mediated decrease in brain-derived neurotrophic factor expression: differential regulation of specific exons by antidepressants and corticosterone. Neuroscience. 2006;139(3):1017-29. doi: 10.1016/j.neuroscience.2005.12.058.
48. Golden E, Emiliano A, Maudsley S, Windham BG, Carlson OD, Egan JM, et al. Circulating brain-derived neurotrophic factor and indices of metabolic and cardiovascular health: data from the Baltimore Longitudinal Study of Aging. PLoS One. 2010;5(4), e10099. doi: 10.1371/journal.pone.0010099.